APOLLO-1: a randomized placebo and active-controlled phase III study investigating oliceridine (TRV130), a G protein-biased ligand at the µ-opioid receptor, for management of moderate-to-severe acute pain following bunionectomy

APOLLO-1: a randomized placebo and active-controlled phase III study investigating oliceridine (TRV130), a G protein-biased ligand at the µ-opioid receptor, for management of moderate-to-severe acute pain following bunionectomy

Eugene R Viscusi,1 Franck Skobieranda,2 David G Soergel,2 Emily Cook,2 David A Burt,2 Neil Singla3 1Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA; 2Trevena Inc., Chesterbrook, PA, USA; 3Lotus Clinical Research, LLC, Pasadena, CA, U...

Full description

Bibliographic Details
Main Authors: Viscusi ER, Skobieranda F, Soergel DG, Cook E, Burt DA, Singla N
Format: Article
Language:English
Published: Dove Medical Press 2019-03-01
Series:Journal of Pain Research
Subjects:
postoperative
analgesia
patient controlled
clinical trial
orthopedic surgery
Online Access:https://www.dovepress.com/apollo-1-a-randomized-placebo-and-active-controlled-phase-iii-study-in-peer-reviewed-article-JPR

Internet

https://www.dovepress.com/apollo-1-a-randomized-placebo-and-active-controlled-phase-iii-study-in-peer-reviewed-article-JPR

Similar Items